Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03575117 · ClinicalTrials.gov registry record · NA
Views on Cancer Prevention and Daily Lifestyle
A NA study, sponsored by University of California, Merced.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT03575117: Completed NA study, sponsored by University of California, Merced.
NCT03575117 is a NA study that has completed, run by University of California, Merced. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03575117, a NA study, has completed, sponsored by University of California, Merced.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
This study is to assess how a theoretically guided mHealth communication informed by evidence of thoughts and affect about colorectal cancer can enhance how an existing mHealth (cell/mobile based text messaging health promotion) intervention increased physical activity in healthy adults.
Primary Outcome
Change from physically active levels in METs at 6 weeks
Interventions
- BEHAVIORAL Common-Sense Model (CSM) Be Well
- BEHAVIORAL ACS usual messages
- BEHAVIORAL NCI HealthyYouTXT--Get Active (HYT--GA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
What the finished NCT03575117 record still lists
NCT03575117 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Common-Sense Model (CSM) Be Well is the first listed.
NCT03575117 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03575117 about?
NCT03575117 is a clinical study titled "Views on Cancer Prevention and Daily Lifestyle". This study is to assess how a theoretically guided mHealth communication informed by evidence of thoughts and affect about colorectal cancer can enhance how an existing mHealth (cell/mobile based text messaging health promotion) intervention increased physical activity in healthy adults.
What is the current status of trial NCT03575117?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2018-05-01. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03575117?
The interventions under investigation include: Common-Sense Model (CSM) Be Well (BEHAVIORAL), ACS usual messages (BEHAVIORAL), NCI HealthyYouTXT--Get Active (HYT--GA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03575117?
This trial is sponsored by University of California, Merced, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03575117's enrollment target sits among peer trials
84 983rd of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI